Table 3.
Loss of Nuclear Immunoreactivity for αABC Correlates with β-Catenin Mutations
| β-Catenin mutation | No β-catenin mutation | Totals | |
|---|---|---|---|
| C Terminus +/αABC + (concordant pattern) | 7 | 32 | 39 |
| C Terminus +/αABC loss (discordant pattern) | 13 | 1 | 14 |
| Totals | 20 | 33 | 53 |
Fisher’s exact test, P < 0.001.
Fifty-three tumors showing a nuclear immunoreactivity for C terminus β-catenin antibodies in a fraction of cells greater than 10% were probed with αABC antibody. Among 14 tumors showing a discordant pattern with C terminus β-catenin antibodies versus αABC (C terminus +/αABC loss), 13 carried mutation of β-catenin. Among the cases showing a concordant pattern of reactivity for C terminus β-catenin antibodies and αABC (C terminus +/αABC +, 39 cases), only 7 carried mutations. These mutations corresponded to D32Y, D32G, and S33F aminoacid substitutions (see Table 4 ▶ ).